RE: BOD share buying - lack of it12 Mar 2025 18:33
Sorry to be annoying, Homer!
I called early this morning and left a message - no reply.
I also sent another email to Corey Burns , project management officer, Office of Orphan Products development, FDA..
I again included the product name, glaucoma, optic fibrosis, nanogenics, and N4Pharma, N4P.
She maintains she has nothing of those names.. she gave me another link and I typed in everything but didn't come up with anything..
I'm taking it 100% that Nigel has submitted this but I am puzzled about the lack of reference.